Preclinical experiments with PRT3789 demonstrated robust inhibition of cell proliferation in SMARCA4-deleted NSCLC in vitro and in PDX tumors ex vivo [88]. The gene discussed is SMARCA4; the disease is non-small cell lung carcinoma.